PLEKHA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.720800E-01
Normal-vs-Stage2
5.584600E-01
Normal-vs-Stage3
4.092800E-01
Normal-vs-Stage4
3.093000E-01
Stage1-vs-Stage2
9.537800E-01
Stage1-vs-Stage3
2.182800E-01
Stage1-vs-Stage4
5.086400E-01
Stage2-vs-Stage3
1.848840E-01
Stage2-vs-Stage4
4.417600E-01
Stage3-vs-Stage4
1.189780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.249000E-01
Normal-vs-AfricanAmerican
2.044200E-01
Normal-vs-Asian
6.689200E-01
Caucasian-vs-AfricanAmerican
4.800500E-02
Caucasian-vs-Asian
7.893800E-01
AfricanAmerican-vs-Asian
2.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.143200E-01
Normal-vs-Female
5.509800E-01
Male-vs-Female
7.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.833200E-01
Normal-vs-Age(41-60Yrs)
2.613800E-01
Normal-vs-Age(61-80Yrs)
7.315600E-01
Normal-vs-Age(81-100Yrs)
6.261400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.777000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.516000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.576800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.077700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.601700E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.979580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.744200E-01
Normal-vs-Daily Drinker
9.811600E-01
Normal-vs-Weekly Drinker
6.914600E-01
Normal-vs-Occasional Drinker
4.528400E-01
Normal-vs-Social Drinker
5.804800E-01
Non Drinker-vs-Daily Drinker
9.073000E-01
Non Drinker-vs-Weekly Drinker
4.425000E-01
Non Drinker-vs-Occasional Drinker
1.091800E-01
Non Drinker-vs-Social Drinker
2.808200E-01
Daily Drinker-vs-Weekly Drinker
4.617600E-01
Daily Drinker-vs-Occasional Drinker
1.465620E-01
Daily Drinker-vs-Social Drinker
3.165800E-01
Weekly Drinker-vs-Occasional Drinker
5.418800E-01
Weekly Drinker-vs-Social Drinker
8.257400E-01
Occasional Drinker-vs-Social Drinker
6.860200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.024050E-01
Normal-vs-Grade 2
1.526390E-02
Normal-vs-Grade 3
2.816200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.711900E-02
Grade 1-vs-Grade 3
3.512200E-01
Grade 1-vs-Grade 4
1.024050E-01
Grade 2-vs-Grade 3
3.324800E-01
Grade 2-vs-Grade 4
1.526390E-02
Grade 3-vs-Grade 4
2.816200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.300600E-01
Normal-vs-NonDiabetic
6.079800E-01
Diabetic-vs-NonDiabetic
1.916190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.412400E-01
Normal-vs-NoPancreatitis
6.547600E-01
Pancreatitis-vs-NoPancreatitis
7.831800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.883800E-01
Normal-vs-N1
5.274400E-01
N0-vs-N1
3.320400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.855400E-01
Normal-vs-TP53-NonMutant
5.855600E-01
TP53-Mutant-vs-TP53-NonMutant
2.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
